Allspring Global Investments
ACAD icon

Allspring Global Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Allspring Global Investments’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.3M Buy
954,855
+296,042
+45% +$7.07M 0.04% 512
2025
Q4 		$17.3M Buy
658,813
+133,393
+25% +$3.19M 0.03% 576
2025
Q3 		$11.2M Buy
525,420
+94,457
+22% +$2.23M 0.02% 684
2025
Q2 		$9.21M Buy
430,963
+120,631
+39% +$2.24M 0.02% 736
2025
Q1 		$5.06M Buy
310,332
+268,714
+646% +$4.88M 0.01% 915
2024
Q4 		$764K Sell
41,618
-80,007
-66% -$1.29M ﹤0.01% 1355
2024
Q3 		$1.87M Buy
121,625
+12,787
+12% +$213K ﹤0.01% 1174
2024
Q2 		$1.77M Buy
108,838
+49,992
+85% +$807K ﹤0.01% 1198
2024
Q1 		$1.09M Sell
58,846
-88,253
-60% -$2.19M ﹤0.01% 1345
2023
Q4 		$4.61M Buy
147,099
+22,008
+18% +$526K 0.01% 972
2023
Q3 		$2.61M Buy
125,091
+87,111
+229% +$2.37M ﹤0.01% 1121
2023
Q2 		$910K Sell
37,980
-51,029
-57% -$1.13M ﹤0.01% 1440
2023
Q1 		$1.68M Buy
89,009
+79,670
+853% +$1.52M ﹤0.01% 1298
2022
Q4 		$149K Sell
9,339
-2,513
-21% -$39.3K ﹤0.01% 1920
2022
Q3 		$193K Buy
11,852
+58
+0.5% +$939 ﹤0.01% 1830
2022
Q2 		$166K Sell
11,794
-50,466
-81% -$942K ﹤0.01% 1877
2022
Q1 		$1.51M Buy
62,260
+3,349
+6% +$81K ﹤0.01% 1653
2021
Q4 		$1.37M Buy
+58,911
New +$1.18M ﹤0.01% 1747

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Allspring Global Investments's ACAD Position: Q1 2026 in Review

Allspring Global Investments increased its Acadia Pharmaceuticals (ACAD) stake by 45% in Q1 2026, buying an estimated $7.07M and bringing the position to 954,855 shares worth $21.3M. The position accounts for 0.04% of the portfolio, ranked #512.

Allspring Global Investments first reported a position in ACAD in Q4 2021 and has held it in 18 quarters since. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Allspring Global Investments held 954,855 shares of Acadia Pharmaceuticals worth $21.3M as of Q1 2026.
  • Allspring Global Investments bought 296,042 Acadia Pharmaceuticals shares in Q1 2026, an estimated $7.07M.
  • Acadia Pharmaceuticals made up 0.04% of Allspring Global Investments's portfolio in Q1 2026, its #512 holding.
  • Allspring Global Investments first reported a position in Acadia Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.